Abstract
Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.
Original language | English |
---|---|
Pages (from-to) | 335-338 |
Journal | Radiotherapy and Oncology |
Volume | 96 |
Issue number | 3 |
DOIs | |
Publication status | Published - Sept 2010 |
Keywords
- Radiotherapy
- PET
- Lung cancer
- Delineation
- Target volumes